# Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma

> **NCT04920162** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 10 (actual)

## Conditions studied

- Melanoma and Vitiligo

## Interventions

- **OTHER:** Biospecimen into patients who had skin diseases

## Key facts

- **NCT ID:** NCT04920162
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-28
- **Primary completion:** 2024-04-05
- **Final completion:** 2024-04-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04920162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04920162, "Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04920162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*